SmartKem, Inc. Reports Unregistered Equity Sales
Ticker: SMTK · Form: 8-K · Filed: Oct 7, 2025 · CIK: 1817760
| Field | Detail |
|---|---|
| Company | Smartkem, Inc. (SMTK) |
| Form Type | 8-K |
| Filed Date | Oct 7, 2025 |
| Risk Level | medium |
| Pages | 6 |
| Reading Time | 7 min |
| Key Dollar Amounts | $0.0001, $500,000, $5,000,000, $1,000,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: unregistered-securities, equity-sale, dilution-risk
TL;DR
SmartKem sold unregistered shares, could mean dilution.
AI Summary
On October 6, 2025, SmartKem, Inc. filed an 8-K report detailing unregistered sales of equity securities and other events. The company, incorporated in Delaware with its principal executive offices in Manchester, UK, is involved in the semiconductors and related devices industry.
Why It Matters
This filing indicates potential dilution for existing shareholders due to the issuance of unregistered equity, which may not have undergone the standard SEC registration process.
Risk Assessment
Risk Level: medium — Unregistered sales of equity can lead to dilution and may signal financial distress or a need for capital outside of traditional public offerings.
Key Players & Entities
- SmartKem, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- October 6, 2025 (date) — Date of earliest event reported
- Manchester, UK (location) — Principal Executive Offices
FAQ
What type of equity securities were sold unregistered?
The filing does not specify the exact type of equity securities sold unregistered, only that unregistered sales of equity securities occurred.
Were these sales made to accredited investors?
The filing does not provide details on the purchasers of the unregistered equity securities, including whether they were accredited investors.
What is the total number of shares sold unregistered?
The filing does not disclose the aggregate number of shares sold in the unregistered equity offering.
What is the purpose of these unregistered equity sales?
The filing does not state the specific purpose or use of proceeds from the unregistered sales of equity securities.
Are there any restrictions on the resale of these unregistered securities?
As these are unregistered securities, they are typically subject to resale restrictions under Rule 144 or other exemptions, though the filing does not detail these specific restrictions.
Filing Stats: 1,709 words · 7 min read · ~6 pages · Grade level 15.3 · Accepted 2025-10-07 13:49:55
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share SMTK The Nasdaq Stock Mar
- $500,000 — ommon shares having a value of at least $500,000 on or prior to November 30, 2025. So lo
- $5,000,000 — gregate gross proceeds of not less than $5,000,000, the Company will purchase from treasur
- $1,000,000 — of such issuances, subject to a cap of $1,000,000. There can be no assurance that the cir
Filing Documents
- tm2528045d1_8k.htm (8-K) — 34KB
- 0001104659-25-097444.txt ( ) — 203KB
- tmb-20251006.xsd (EX-101.SCH) — 3KB
- tmb-20251006_lab.xml (EX-101.LAB) — 33KB
- tmb-20251006_pre.xml (EX-101.PRE) — 22KB
- tm2528045d1_8k_htm.xml (XML) — 4KB
02 Unregistered
Item 3.02 Unregistered Sales of Equity Securities. On October 7, 2025, SmartKem, Inc. (the "Company") entered into agreements with two consulting firms to provide investor relations related services to the Company, and in consideration for such services, agreed to issue up 500,000 shares (the "Shares") of common stock of the Company, par value $0.0001 per share (the "Common Stock"), subject to certain restrictions. The Shares will be issued and sold in reliance upon the exemption from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"), afforded by Section 4(a)(2) of the Securities Act. The Company may enter into similar agreements in the future. On July 1, 2025, the Company issued 10,000 shares of Common Stock to a vendor as consideration for consulting services. Such issuance was exempt from registration under 4(a)(2) of the Securities Act. On August 1, 2025, the Company issued 10,000 shares of Common Stock to a vendor as consideration for consulting services. Such issuance was exempt from registration under 4(a)(2) of the Securities Act. On September 2, 2025, the Company issued 10,000 shares of Common Stock to a vendor as consideration for consulting services. Such issuance was exempt from registration under 4(a)(2) of the Securities Act.
01 Other Events
Item 8.01 Other Events. On October 6, 2025, the Company entered into a non-binding letter of intent (the "LOI") with Jericho Energy Ventures Inc. ("Jericho"), an energy innovation company, to pursue a potential business combination (the "Proposed Transaction"). Under the LOI, the Proposed Transaction would be structured as an all-stock business combination, effected through either a share exchange or statutory merger, pursuant to which the Company would be the surviving legal entity and would continue as a publicly listed company on The Nasdaq Stock Market ("Nasdaq") (such surviving company, the "Combined Company"). Upon the closing of the Proposed Transaction, Jericho stockholders would own 65% and Company stockholders prior to the Proposed Transaction would own 35% of the fully diluted issued and outstanding equity securities of the Combined Company, subject to adjustment in certain circumstances. Brian Williamson, the current chief executive officer of Jericho, would become the chief executive officer of the Combined Company, and the board of directors of the Combined Company would be reconstituted to include a majority of members designated by Jericho, The LOI is non-binding, and there can be no assurance that the Company and Jericho will ultimately enter into a definitive agreement for the Proposed Transaction, that the Proposed Transaction will be consummated, or as to the timing or ultimate terms of any Proposed Transaction that may occur. Both the Company and Jericho will need significant additional capital to complete the negotiation of the Proposed Transaction, obtain any required stockholder approvals and ultimately complete the Proposed Transaction. The closing of the Proposed Transaction would be subject to significant closing conditions, including the negotiation of the definitive agreement, the satisfactory completion of due diligence, required
Forward-Looking Statements
Forward-Looking Statements The disclosure herein includes certain statements that are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect," "should," "would," "plan," "predict," "potential," "seem," "seek," "future," "outlook," and similar expressions that predict or indicate future events or trends or that are not ability to (i) satisfy the requirements of the LOI, including obtaining the necessary additional capital required to purchase Jericho common shares, (ii) negotiate a definitive agreement for the Proposed Transaction on the terms set forth in the LOI, (iii) satisfy the conditions precedent to the Proposed Transaction, including the receipt of any required stockholder or Nasdaq approval, (iv) consummate the Proposed Transaction on the terms set forth in the LOI, or (v) obtain the capital necessary to complete the negotiation and consummation of the Proposed Transaction. These statements are based on various assumptions and on the current expectations of the Company's management and are not predictions of actual performance. These forward-looking statements are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction, or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of the Company. These forward-looking statements are subject to a number of risks and uncertainties, including: the Company's ability to enter into a definitive agreement with respect t